BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29229583)

  • 1. Integrative Genomic Analysis of Coincident Cancer Foci Implicates CTNNB1 and PTEN Alterations in Ductal Prostate Cancer.
    Gillard M; Lack J; Pontier A; Gandla D; Hatcher D; Sowalsky AG; Rodriguez-Nieves J; Vander Griend D; Paner G; VanderWeele D
    Eur Urol Focus; 2019 May; 5(3):433-442. PubMed ID: 29229583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ductal and acinar components of mixed prostatic adenocarcinoma frequently have a common clonal origin.
    Lindh C; Samaratunga H; Delahunt B; Bergström R; Chellappa V; Yaxley J; Lindberg J; Egevad L
    Prostate; 2022 Apr; 82(5):576-583. PubMed ID: 35049068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIN-like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations.
    Kaur HB; Salles DC; Paulk A; Epstein JI; Eshleman JR; Lotan TL
    Histopathology; 2021 Jan; 78(2):327-333. PubMed ID: 32740981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiles of ductal versus acinar adenocarcinoma of the prostate.
    Sanati S; Watson MA; Salavaggione AL; Humphrey PA
    Mod Pathol; 2009 Oct; 22(10):1273-9. PubMed ID: 19633648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas.
    Morais CL; Herawi M; Toubaji A; Albadine R; Hicks J; Netto GJ; De Marzo AM; Epstein JI; Lotan TL
    Prostate; 2015 Oct; 75(14):1610-9. PubMed ID: 26178158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas.
    Lotan TL; Toubaji A; Albadine R; Latour M; Herawi M; Meeker AK; DeMarzo AM; Platz EA; Epstein JI; Netto GJ
    Mod Pathol; 2009 Mar; 22(3):359-65. PubMed ID: 19151660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal Adenocarcinoma of the Prostate with Novel Genetic Alterations Characterized by Next-Generation Sequencing.
    Zara Rozalen A; Martin JM; Rajendran R; Jain M; Nava VE
    Curr Oncol; 2024 Mar; 31(3):1556-1561. PubMed ID: 38534951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutations.
    Khani F; Wobker SE; Hicks JL; Robinson BD; Barbieri CE; De Marzo AM; Epstein JI; Pritchard CC; Lotan TL
    J Pathol; 2019 Sep; 249(1):79-89. PubMed ID: 30993692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostatic ductal adenocarcinoma with cribriform architecture has worse prognostic features than non-cribriform-type.
    Au S; Villamil CF; Alaghehbandan R; Wang G
    Ann Diagn Pathol; 2019 Apr; 39():59-62. PubMed ID: 30772651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent Mutations in APC and CTNNB1 and Activated Wnt/β-catenin Signaling in Intraductal Papillary Neoplasms of the Bile Duct: A Whole Exome Sequencing Study.
    Fujikura K; Akita M; Ajiki T; Fukumoto T; Itoh T; Zen Y
    Am J Surg Pathol; 2018 Dec; 42(12):1674-1685. PubMed ID: 30212390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic stage of prostatic ductal adenocarcinoma at radical prostatectomy: effect of percentage of the ductal component and associated grade of acinar adenocarcinoma.
    Amin A; Epstein JI
    Am J Surg Pathol; 2011 Apr; 35(4):615-9. PubMed ID: 21383610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple Origin and Tumor Heterogeneity of Prostatic Ductal Adenocarcinoma in the Han Chinese Population.
    Zhang W; Su F; Wang M; Hou H; Liu M; Liu D; Liu H
    Genet Test Mol Biomarkers; 2021 Nov; 25(11):727-732. PubMed ID: 34788144
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunohistochemical verification of ductal differentiation in prostate cancer.
    Tarján M; Lenngren A; Hellberg D; Tot T
    APMIS; 2012 Jun; 120(6):510-8. PubMed ID: 22583364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features of prostate ductal carcinoma: matching analysis and comparison with prostate acinar carcinoma.
    Kim A; Kwon T; You D; Jeong IG; Go H; Cho YM; Hong JH; Ahn H; Kim CS
    J Korean Med Sci; 2015 Apr; 30(4):385-9. PubMed ID: 25829805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic ductal adenocarcinoma variant predicts worse pathological and oncological outcomes: Insight from over 1000 consecutive patients from a large prospective uro-oncology registry.
    Tan YG; Khalid F; Huang HH; Chen K; Tay KJ; Lau WKO; Cheng CWS; Ngo NT; Yuen JSP
    Prostate; 2021 Mar; 81(4):242-251. PubMed ID: 33428259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic profile of ductal adenocarcinoma of the prostate.
    Seipel AH; Whitington T; Delahunt B; Samaratunga H; Mayrhofer M; Wiklund P; Grönberg H; Lindberg J; Egevad L
    Hum Pathol; 2017 Nov; 69():1-7. PubMed ID: 28457729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed primary prostatic carcinoma with acinar, neuroendocrine and ductal components.
    Romero-Rojas AE; Diaz-Perez JA; Reddy A
    Arch Ital Urol Androl; 2014 Jun; 86(2):150-1. PubMed ID: 25017603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival.
    Chow K; Bedő J; Ryan A; Agarwal D; Bolton D; Chan Y; Dundee P; Frydenberg M; Furrer MA; Goad J; Gyomber D; Hanegbi U; Harewood L; King D; Lamb AD; Lawrentschuk N; Liodakis P; Moon D; Murphy DG; Peters JS; Ruljancich P; Verrill CL; Webb D; Wong LM; Zargar H; Costello AJ; Papenfuss AT; Hovens CM; Corcoran NM
    Eur J Cancer; 2021 May; 148():440-450. PubMed ID: 33678516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic Heterogeneity Within Individual Prostate Cancer Foci Impacts Predictive Biomarkers of Targeted Therapy.
    VanderWeele DJ; Finney R; Katayama K; Gillard M; Paner G; Imoto S; Yamaguchi R; Wheeler D; Lack J; Cam M; Pontier A; Nguyen YTM; Maejima K; Sasaki-Oku A; Nakano K; Tanaka H; Vander Griend D; Kubo M; Ratain MJ; Miyano S; Nakagawa H
    Eur Urol Focus; 2019 May; 5(3):416-424. PubMed ID: 29398457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Japanese patient with ductal carcinoma of the prostate carrying an adenomatosis polyposis coli gene mutation: a case report.
    Umeda K; Kosaka T; Nakamura K; Takeda T; Mikami S; Nishihara H; Oya M
    Diagn Pathol; 2020 Aug; 15(1):102. PubMed ID: 32758244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.